Pfizer Inc. PFE said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX for $110 to $130 per dose once the U.S. market for COVID-19 shots becomes commercial, likely in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback